skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index
Refined by: subject: Obesity - Complications remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Effects of liraglutide in the treatment of obesity: a randomised, double-blind, placebo-controlled study
Material Type:
Article
Add to My Research

Effects of liraglutide in the treatment of obesity: a randomised, double-blind, placebo-controlled study

The Lancet (British edition), 2009-11, Vol.374 (9701), p.1606-1616 [Peer Reviewed Journal]

Elsevier Ltd ;2009 Elsevier Ltd ;2009 INIST-CNRS ;Copyright Elsevier Limited Nov 7-Nov 13, 2009 ;ISSN: 0140-6736 ;ISSN: 1474-547X ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(09)61375-1 ;PMID: 19853906 ;CODEN: LANCAO

Full text available

2
Effect of Sibutramine on Cardiovascular Outcomes in Overweight and Obese Subjects
Material Type:
Article
Add to My Research

Effect of Sibutramine on Cardiovascular Outcomes in Overweight and Obese Subjects

The New England journal of medicine, 2010-09, Vol.363 (10), p.905-917 [Peer Reviewed Journal]

Copyright © 2010 Massachusetts Medical Society. All rights reserved. ;2015 INIST-CNRS ;ISSN: 0028-4793 ;ISSN: 1533-4406 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMoa1003114 ;PMID: 20818901 ;CODEN: NEJMAG

Full text available

3
Prevalence, Pathophysiology, Health Consequences and Treatment Options of Obesity in the Elderly: A Guideline
Material Type:
Article
Add to My Research

Prevalence, Pathophysiology, Health Consequences and Treatment Options of Obesity in the Elderly: A Guideline

Obesity facts, 2012, Vol.5 (3), p.460-483 [Peer Reviewed Journal]

2012 S. Karger GmbH, Freiburg ;ISSN: 1662-4025 ;EISSN: 1662-4033 ;DOI: 10.1159/000341193 ;PMID: 22797374

Full text available

4
Efficacy and tolerability of rimonabant in overweight or obese patients with type 2 diabetes: a randomised controlled study
Material Type:
Article
Add to My Research

Efficacy and tolerability of rimonabant in overweight or obese patients with type 2 diabetes: a randomised controlled study

The Lancet (British edition), 2006-11, Vol.368 (9548), p.1660-1672 [Peer Reviewed Journal]

2006 Elsevier Ltd ;Copyright Lancet Ltd. Nov 11-Nov 17, 2006 ;ISSN: 0140-6736 ;ISSN: 1474-547X ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(06)69571-8 ;PMID: 17098084 ;CODEN: LANCAO

Full text available

5
Association of Hypoglycemic Treatment Regimens With Cardiovascular Outcomes in Overweight and Obese Subjects With Type 2 Diabetes: A substudy of the SCOUT trial
Material Type:
Article
Add to My Research

Association of Hypoglycemic Treatment Regimens With Cardiovascular Outcomes in Overweight and Obese Subjects With Type 2 Diabetes: A substudy of the SCOUT trial

Diabetes care, 2013-11, Vol.36 (11), p.3746-3753 [Peer Reviewed Journal]

2014 INIST-CNRS ;COPYRIGHT 2013 American Diabetes Association ;Copyright American Diabetes Association Nov 2013 ;2013 by the American Diabetes Association. 2013 ;ISSN: 0149-5992 ;EISSN: 1935-5548 ;DOI: 10.2337/dc13-0027 ;PMID: 24089540 ;CODEN: DICAD2

Full text available

6
Obesity and risk of myocardial infarction: the INTERHEART study
Material Type:
Article
Add to My Research

Obesity and risk of myocardial infarction: the INTERHEART study

The Lancet (British edition), 2006-04, Vol.367 (9516), p.1053-1053 [Peer Reviewed Journal]

2006 Elsevier Ltd ;Copyright Elsevier Limited Apr 1, 2006 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(06)68463-8 ;PMID: 16581396

Full text available

7
Efficacy and Safety of CP-945,598, a Selective Cannabinoid CB1 Receptor Antagonist, on Weight Loss and Maintenance
Material Type:
Article
Add to My Research

Efficacy and Safety of CP-945,598, a Selective Cannabinoid CB1 Receptor Antagonist, on Weight Loss and Maintenance

Obesity (Silver Spring, Md.), 2011-07, Vol.19 (7), p.1404-1414 [Peer Reviewed Journal]

2011 North American Association for the Study of Obesity (NAASO) ;Copyright Nature Publishing Group Jul 2011 ;ISSN: 1930-7381 ;EISSN: 1930-739X ;DOI: 10.1038/oby.2010.352 ;PMID: 21293451

Full text available

8
Quantitative Magnetic Resonance (QMR) for Longitudinal Evaluation of Body Composition Changes With Two Dietary Regimens
Material Type:
Article
Add to My Research

Quantitative Magnetic Resonance (QMR) for Longitudinal Evaluation of Body Composition Changes With Two Dietary Regimens

Obesity (Silver Spring, Md.), 2010-02, Vol.18 (2), p.391-396 [Peer Reviewed Journal]

2010 North American Association for the Study of Obesity (NAASO) ;ISSN: 1930-7381 ;EISSN: 1930-739X ;DOI: 10.1038/oby.2009.272 ;PMID: 19696753

Full text available

9
Obesity and risk of myocardial infarction: the INTERHEART study
Material Type:
Article
Add to My Research

Obesity and risk of myocardial infarction: the INTERHEART study

The Lancet (British edition), 2006-04, Vol.367 (9516), p.1053-1054 [Peer Reviewed Journal]

2006 Elsevier Ltd ;Copyright Elsevier Limited Apr 1, 2006 ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(06)68464-X ;PMID: 16581397

Full text available

10
The impact of obesity on drug prescribing in primary care
Material Type:
Article
Add to My Research

The impact of obesity on drug prescribing in primary care

British journal of general practice, 2005-10, Vol.55 (519), p.743-749 [Peer Reviewed Journal]

British Journal of General Practice, 2005. 2005 ;ISSN: 0960-1643 ;EISSN: 1478-5242 ;PMID: 16212848

Full text available

11
Emerging pharmacotherapy for treating obesity and associated cardiometabolic risk
Material Type:
Article
Add to My Research

Emerging pharmacotherapy for treating obesity and associated cardiometabolic risk

Asia Pacific journal of clinical nutrition, 2006-09, Vol.15 Suppl, p.55 [Peer Reviewed Journal]

ISSN: 0964-7058 ;EISSN: 1440-6047 ;PMID: 16928662

Full text available

Searching Remote Databases, Please Wait